Pericyte NNMT drives an immune-hostile vascular niche and restricts cancer immunotherapy

Sci Bull (Beijing). 2026 Apr 30;71(8):1912-1916. doi: 10.1016/j.scib.2026.02.001. Epub 2026 Feb 5.
No abstract available